Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5.
Gazzah A, Ricordel C, Italiano A, Cho BC, Calvo E, Kim DW, Helissey C, Kim JS, Villar MV, Ghiringhelli F, Moreno V, Cousin S, Paz-Ares L, Fagniez N, Chadjaa M, Bauchet AL, Soufflet C, Masson N, Barlesi F.
Gazzah A, et al. Among authors: kim js.
JTO Clin Res Rep. 2025 May 15;6(10):100844. doi: 10.1016/j.jtocrr.2025.100844. eCollection 2025 Oct.
JTO Clin Res Rep. 2025.
PMID: 41031047
Free PMC article.